benign prostatic hyperplasia
Conditions
Interventions
120W group:120Wholep surgery
100W group:100Wholep surgery
Sponsors
Shanghai Ninth People Hospital affiliated to Shanghai JiaoTong University, School of Medicine
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: The inclusion criteria for the study were indications for the surgical treatment of BPH. ;Inclusion criteria: The inclusion criteria for the study were indications for the surgical treatment of BPH. ;Inclusion criteria: The inclusion criteria for the study were indications for the surgical treatment of BPH. ;Inclusion criteria: The inclusion criteria for the study were indications for the surgical treatment of BPH. ;Inclusion criteria: The inclusion criteria for the study were indications for the surgical treatment of BPH.
Exclusion criteria
Exclusion criteria: Patients with severe pulmonary disease or heart disease, bladder calculus, neurogenic bladder dysfunction, bladder cancer, previous prostate surgery, prostate cancer, urethral stricture or coagulopathy will be excluded from the study. ;Exclusion criteria: Patients with severe pulmonary disease or heart disease, bladder calculus, neurogenic bladder dysfunction, bladder cancer, previous prostate surgery, prostate cancer, urethral stricture or coagulopathy will be excluded from the study. ;Exclusion criteria: Patients with severe pulmonary disease or heart disease, bladder calculus, neurogenic bladder dysfunction, bladder cancer, previous prostate surgery, prostate cancer, urethral stricture or coagulopathy will be excluded from the study. ;Exclusion criteria: Patients with severe pulmonary disease or heart disease, bladder calculus, neurogenic bladder dysfunction, bladder cancer, previous prostate surgery, prostate cancer, urethral stricture or coagulopathy will be excluded from the study. ;Exclusion criteria: Patients with severe pulmonary disease or heart disease, bladder calculus, neurogenic bladder dysfunction, bladder cancer, previous prostate surgery, prostate cancer, urethral stricture or coagulopathy will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Qmax;IPSS;QoL; | — |
Countries
China
Contacts
Public ContactWang Zhong;Wang Zhong;Wang Zhong;Wang Zhong;Wang Zhong ;;;;
Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine;Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine;Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine;Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine;Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine
Outcome results
None listed